Cargando…
Advanced CRISPR-Cas Effector Enzyme-Based Diagnostics for Infectious Diseases, Including COVID-19
Rapid and precise diagnostic tests can prevent the spread of diseases, including worldwide pandemics. Current commonly used diagnostic methods include nucleic-acid-amplification-based detection methods and immunoassays. These techniques, however, have several drawbacks in diagnosis time, accuracy, a...
Autores principales: | Kwon, Sangha, Shin, Ha Youn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705966/ https://www.ncbi.nlm.nih.gov/pubmed/34947888 http://dx.doi.org/10.3390/life11121356 |
Ejemplares similares
-
Structure of the type V-C CRISPR-Cas effector enzyme
por: Kurihara, Nina, et al.
Publicado: (2022) -
Mechanistic and evolutionary insights into a type V-M CRISPR–Cas effector enzyme
por: Omura, Satoshi N., et al.
Publicado: (2023) -
Recent advances in the use of the CRISPR-Cas system for the detection of infectious pathogens
por: GAO, Hongdan, et al.
Publicado: (2022) -
Defining the seed sequence of the Cas12b CRISPR-Cas effector complex
por: Jain, Ishita, et al.
Publicado: (2018) -
CRISPR-Cas systems for diagnosing infectious diseases
por: Kostyusheva, Anastasiya, et al.
Publicado: (2022)